Founded in 2019, Symbionic operates in Health Tech, offering advanced bionic prostheses for people with missing limbs. The company focuses on utilising technology to improve the quality of life for it...
Funding stage:
Grant
Last funding:
04/12/2022
Total funding:
$20.00K+
Revenue:
Investors
Employee count:
15
Last 90d
15
Last 90d
Web traffic:
1.68K
1.68K
Last 30d
Last 30d
Glassdoor Rating:
Symbionic: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders14
Latest Filing Date30 March 2024- Funding Events16
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Symbionic
As of 31 March 2024, Symbionic's equity is held by 12 shareholders, with the top three being Rishi Krishna, Gofrugal, and Bipin Vazirani Family Trust.
Rishi Krishna holds the largest stake in Symbionic at 49.0% as of 31 March 2024.
As of 31 March 2024, founders collectively hold 54.4% equity in Symbionic.
As of 31 March 2024, investors collectively hold 17.8% equity in Symbionic.
Symbionic's ESOP pool stands at 10.3% of total equity as of 31 March 2024.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links